Plano, TX – (February 1, 2017) – Pharmaceutical Strategies Group, an integrated technology-enabled pharmacy solutions and cost-containment company, has rebranded its 340B solutions and will be unveiling PSG 340B Link™ at the 340B Coalition Winter Conference being held in San Francisco, CA, from February 1-3. PSG 340B Link is a comprehensive 340B solution with a proven record of delivering a flexible deployment and unparalleled service to assist in optimizing both savings and compliance.
The 340B Link suite of solutions highlights PSG’s 340B product pillars: Network Link™, Specialty Link™, Order Link™ and Community Link™.
“When PSG entered the 340B market, our goal was to offer a total solution,” said Dave Borden, PSG CEO, “one that combined great technology with a truly consultative approach to navigating the program. This new representation of our 340B solutions clearly shows we are evolving as a company by expanding our product offerings, pushing into new markets and continuing along our path of innovation, while continuing our legacy of excellence in serving our customers.”
PSG’s new branding is the positive outcome of the company’s broadening footprint across the 340B program and increasing recognition across the United States. 340B Link represents PSG’s success and ongoing mission to empower clients to maximize savings from all pharmacies – including mixed-use, owned retail, contract retail and contract specialty.
“The 340B program has gone through tremendous change over the past few years, and PSG continues to provide flexible solutions to meet the unique needs of hospitals,” said Mickey Price, President, PSG 340B. “Our new brand identities better represent where the company is today, where we are heading, and our vision for the future.”
About Pharmaceutical Strategies Group
Pharmaceutical Strategies Group (PSG), based in Plano, Texas, is the largest independent pharmacy program consulting firm in the U.S. PSG designs and implements custom and creative pharmacy benefit management, clinical and supply chain solutions that allow clients to greatly maximize the value of pharmaceuticals across their operations. PSG generated more than $2 billion in cost savings for its 300-plus clients, representing improved outcomes to 100 million lives in the last two years. The 21-year-old company’s clients include health plans, hospitals and health systems, labor unions, coalitions and self-insured employers. For more information, please visit www.psgconsults.com.